Animal Health LatAm 2019

Animal Health Innovation Latin America

Business Development & Partnering

View the Agenda
São Paulo, Brazil
6-7 August, 2019

“There is no other event in the region that offers so much knowledge sharing and networking opportunities”

Esteban Corrales, Director, Labyes

Why Attend

Animal Health Innovation Latin America returns for 2019, as an extension of our already successful series in Europe, USA and Asia. The forum brings start-ups and biotech companies together with financial investors and multinational companies to better stimulate the growth of the animal health industry and the speed of innovation through partnerships and investment.

The Forum combines efficient 1-on-1 meetings with educational content, pitching sessions and high-level keynote talks from global leaders.

We have live translation of all sessions available in English and Portuguese.
 
 
 
200+
Attendees
50+
Start-ups
15+
1-to-1 Meetings per person

Highlights from 2018

University Pavilion

Connecting Academia with Business Partners

Top Universities and Tech Transfer Hubs in Latin America will participate and share details on their latest research and technology. Each instititon will bring with them a start-up company that is currently looking for strategic partners.

 
University Pavilion, Animal Health Latam 2019

Resources

Download Resource

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

You may withdraw this consent at any time by emailing us at [email protected].
To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Who Attends?

Attendees from the Animal Health Latam series

Global Advisory Board

Author:

Joachim Hasenmaier

Independent Animal Health Expert

Joachim Hasenmaier, born 1960 in Vaihingen/Enz, Germany, DVM., is Member of the Board of Managing Directors of C.H. Boehringer Sohn AG & Co. KG since October 1, 2012, responsible for the Corporate Board Division Consumer Health Care and Animal Health. His nationality is German.

He received a veterinary medical degree (DVM) in 1986 from Ludwig-Maximilians-University, Munich, where he entered into a microbiological research program until 1989 receiving his Doktor med. vet. (PhD) degree. He completed his education with a Master in Management from Kellogg Business School, Chicago, USA in 1991. Prior to joining BI he worked in various positions for various international companies in Germany, Japan, Mexico and Brazil.

In 2002 he joined Boehringer Ingeheim as Corporate Senior Vice President for Boehringer Ingelheim Animal Health. In 2011 he took over the regional responsibilty for Prescription Medicine in NECAR (UK/Ireland, Nordics, Benelux, Canada, Australia/New Zealand). He held this position until he became Member of the Board of Managing Directors at C.H. Boehringer Sohn AG & Co. KG in October 2012.

Joachim Hasenmaier

Independent Animal Health Expert

Joachim Hasenmaier, born 1960 in Vaihingen/Enz, Germany, DVM., is Member of the Board of Managing Directors of C.H. Boehringer Sohn AG & Co. KG since October 1, 2012, responsible for the Corporate Board Division Consumer Health Care and Animal Health. His nationality is German.

He received a veterinary medical degree (DVM) in 1986 from Ludwig-Maximilians-University, Munich, where he entered into a microbiological research program until 1989 receiving his Doktor med. vet. (PhD) degree. He completed his education with a Master in Management from Kellogg Business School, Chicago, USA in 1991. Prior to joining BI he worked in various positions for various international companies in Germany, Japan, Mexico and Brazil.

In 2002 he joined Boehringer Ingeheim as Corporate Senior Vice President for Boehringer Ingelheim Animal Health. In 2011 he took over the regional responsibilty for Prescription Medicine in NECAR (UK/Ireland, Nordics, Benelux, Canada, Australia/New Zealand). He held this position until he became Member of the Board of Managing Directors at C.H. Boehringer Sohn AG & Co. KG in October 2012.

Author:

Clinton Lewis

Executive Vice President, President, International Operations
ZOETIS

Clint Lewis is executive vice president and president of International Operations at Zoetis. In this role, he oversees the management of the livestock and companion animal business markets outside the United States.
Mr. Lewis previously served as president, U.S. Operations at Zoetis and in the Pfizer Animal Health organization. He joined Pfizer Animal Health in 2007.

Mr. Lewis joined Pfizer in 1988 as a sales representative in Long Island, N.Y., and has held positions of increasing responsibility in several areas across various commercial operations dedicated to human health prior to joining animal health, including vice president and general manager of Pfizer’s U.S. Anti-Infectives/HIV business unit.

In 2011, Mr. Lewis was elected chairman of the Animal Health Institute (AHI) for the 2011-12 term. A member of AHI since 2007, Mr. Lewis previously served as AHI vice chair for the 2009-2010 term. AHI is the trade association for the animal health industry in the U.S. advocating on various issues important to the industry, including efficient and effective regulatory and approval processes by the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA).

Mr. Lewis holds a bachelor’s degree in biology from Fairfield University and a Master of Business Administration in marketing from Fairleigh Dickinson University.

Clinton Lewis

Executive Vice President, President, International Operations
ZOETIS

Clint Lewis is executive vice president and president of International Operations at Zoetis. In this role, he oversees the management of the livestock and companion animal business markets outside the United States.
Mr. Lewis previously served as president, U.S. Operations at Zoetis and in the Pfizer Animal Health organization. He joined Pfizer Animal Health in 2007.

Mr. Lewis joined Pfizer in 1988 as a sales representative in Long Island, N.Y., and has held positions of increasing responsibility in several areas across various commercial operations dedicated to human health prior to joining animal health, including vice president and general manager of Pfizer’s U.S. Anti-Infectives/HIV business unit.

In 2011, Mr. Lewis was elected chairman of the Animal Health Institute (AHI) for the 2011-12 term. A member of AHI since 2007, Mr. Lewis previously served as AHI vice chair for the 2009-2010 term. AHI is the trade association for the animal health industry in the U.S. advocating on various issues important to the industry, including efficient and effective regulatory and approval processes by the U.S. Department of Agriculture (USDA), the Food and Drug Administration (FDA), and the Environmental Protection Agency (EPA).

Mr. Lewis holds a bachelor’s degree in biology from Fairfield University and a Master of Business Administration in marketing from Fairleigh Dickinson University.

Author:

Dirk Ehle

Head of Bayer Animal Health
Bayer

Dr. Dirk Ehle has been a member of the Bayer HealthCare Executive Committee and responsible for the Animal Health Division since May 1, 2012.

Dirk Ehle was born on May 26, 1969, in Cologne, Germany. He studied law at the universities of Freiburg, Aix-en-Provence (France), Wurzburg, and New York (USA).

After three years in law firms, Dirk Ehle started his career at Bayer in 2001 in the Law Department of Bayer HealthCare. In 2006, Ehle transferred to Bayer AG’s Corporate Office where he worked as Executive Assistant to the Chairman of the Board of Management. He was also in charge of Corporate Policy & Advocacy as of 2008. In 2010, Ehle was appointed Senior Bayer Representative for Central Eastern Europe and Bayer HealthCare Representative for Poland.

Dirk Ehle is married with three children.

Dirk Ehle

Head of Bayer Animal Health
Bayer

Dr. Dirk Ehle has been a member of the Bayer HealthCare Executive Committee and responsible for the Animal Health Division since May 1, 2012.

Dirk Ehle was born on May 26, 1969, in Cologne, Germany. He studied law at the universities of Freiburg, Aix-en-Provence (France), Wurzburg, and New York (USA).

After three years in law firms, Dirk Ehle started his career at Bayer in 2001 in the Law Department of Bayer HealthCare. In 2006, Ehle transferred to Bayer AG’s Corporate Office where he worked as Executive Assistant to the Chairman of the Board of Management. He was also in charge of Corporate Policy & Advocacy as of 2008. In 2010, Ehle was appointed Senior Bayer Representative for Central Eastern Europe and Bayer HealthCare Representative for Poland.

Dirk Ehle is married with three children.

Author:

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

Linda Rhodes

VMD, PhD, Independent and ex-CSO
Independent Animal Health

Dr. Rhodes has over 30 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.

Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has an extensive background in physiology, veterinary medicine, and drug development, and many publications in peer-reviewed journals. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. As a senior research fellow at Merck Research Laboratories for 8 years, she led pre-clinical biology evaluation of several marketed human drugs. She worked for Merial Ltd. as director of large animal development projects, leading project teams developing novel compounds for a variety of indications. In April 2001, she formed AlcheraBio, a consulting, marketing, and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies world-wide. AlcheraBio was acquired in 2008 by Argenta, and Dr. Rhodes served as executive vice president to transition the company when in 2011, she accepted a position as CEO of Aratana Therapeutics, a startup company developing innovative new medicines for dogs and cats. Subsequently, when the company became public she served as its Chief Scientific Officer. During her 5-year tenure, the company achieved FDA approval of three new pet therapeutics: Galliprant, Nocita and Entyce. She is currently retired and an independent consultant. She is a member of the Board of Directors of Zoetis, and serves on the Scientific Advisory Boards of the Alliance for Contraception in Dogs and Cats and the Michelson Found Animals Foundation. She founded Feather in Her Cap, a non-profit that recognizes the achievement of women in the animal health industry. She is the recipient of the Iron Paw Award.

Author:

George Gunn

Founder and Partner
Stonehaven Consulting AG

George Gunn

Founder and Partner
Stonehaven Consulting AG

Author:

Aaron Schacht

CEO
BiomEdit

Aaron Schacht

CEO
BiomEdit

Author:

Jean Deleforge

Chief Scientific Officer
Vetoquinol

Jean Deleforge

Chief Scientific Officer
Vetoquinol

Author:

Alan Mackay

Executive Partner and Founder
GHO Capital

Alan has been a private equity investor for more than 25 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. Alan has served on the boards of a number of healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014. Latterly he has been Managing Partner, CEO, and Chairman of the Investment Committee, of Hermes GPE, an active co-investor in private equity backed healthcare. Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He is Chair of the BVCA for 2016 – 2017 and previously chaired its Responsible Investment Advisory Board.

Alan Mackay

Executive Partner and Founder
GHO Capital

Alan has been a private equity investor for more than 25 years in roles including Senior Partner and Global Head of Healthcare at the private equity firm 3i Group plc. He was appointed to the board of 3i plc in 1993 and became CEO of 3i Nordic plc, based in Stockholm, upon the acquisition of Sweden's largest listed private equity company Atle AB in 2001. Alan has served on the boards of a number of healthcare companies, including most recently Phibro Animal Health Corporation which completed a successful initial public offering (IPO) in April 2014. Latterly he has been Managing Partner, CEO, and Chairman of the Investment Committee, of Hermes GPE, an active co-investor in private equity backed healthcare. Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He is Chair of the BVCA for 2016 – 2017 and previously chaired its Responsible Investment Advisory Board.

Author:

Dr. James Lloyd

Dean of the College and Professor
University of Florida, Colleague of Veterinary Medicine

Education

  • PhD, Agricultural Economics & Operations Research, Michigan State University, 1989
  • DVM, Michigan State University, 1981
  • BS, Fisheries & Wildlife, Michigan State University, 1978

Honors and Awards

  • LGVMA Leadership Award, 2013
  • President’s Honor Roll, Michigan Veterinary Medical Association, 2006, 2007, 2008, 2009, 2011
  • Senior Fellow, Outreach and Engagement, Michigan State University, 2005-13
  • Certificate of Appreciation, Assoc. of Vet. Practice Management Consultants and Advisors, 2004
  • Norden Teacher of the Year Award Finalist, College of Veterinary Medicine, 2003
  • Creativity in Teaching Award, Merck Agvet, 1995
  • State Team Award, Milk Quality Assurance Program, Michigan State University Extension, 1993
  • Commendation (for Extension activity), Michigan Cattlemen’s Association, 1992
  • The Honor Society of Phi Kappa Phi, Michigan State University, inducted 1985
  • Phi Zeta, Honorary Veterinary Society, Michigan State University, inducted 1981
  • Butler Award, voted by peers as “most likely to succeed” in large animal veterinary medicine, 1981
  • Honors College, Michigan State University, 1975 to 1977

Interests

Dr. Lloyd was leader of the National Commission on Veterinary Economic Issues working group on Enhancing the Skills, Knowledge, Aptitude, and Attitude of Veterinarians from 2000-2009. He also works as an organization development consultant, emphasizing strategic planning and leadership development with inclusion as a core element.

Dr. James Lloyd

Dean of the College and Professor
University of Florida, Colleague of Veterinary Medicine

Education

  • PhD, Agricultural Economics & Operations Research, Michigan State University, 1989
  • DVM, Michigan State University, 1981
  • BS, Fisheries & Wildlife, Michigan State University, 1978

Honors and Awards

  • LGVMA Leadership Award, 2013
  • President’s Honor Roll, Michigan Veterinary Medical Association, 2006, 2007, 2008, 2009, 2011
  • Senior Fellow, Outreach and Engagement, Michigan State University, 2005-13
  • Certificate of Appreciation, Assoc. of Vet. Practice Management Consultants and Advisors, 2004
  • Norden Teacher of the Year Award Finalist, College of Veterinary Medicine, 2003
  • Creativity in Teaching Award, Merck Agvet, 1995
  • State Team Award, Milk Quality Assurance Program, Michigan State University Extension, 1993
  • Commendation (for Extension activity), Michigan Cattlemen’s Association, 1992
  • The Honor Society of Phi Kappa Phi, Michigan State University, inducted 1985
  • Phi Zeta, Honorary Veterinary Society, Michigan State University, inducted 1981
  • Butler Award, voted by peers as “most likely to succeed” in large animal veterinary medicine, 1981
  • Honors College, Michigan State University, 1975 to 1977

Interests

Dr. Lloyd was leader of the National Commission on Veterinary Economic Issues working group on Enhancing the Skills, Knowledge, Aptitude, and Attitude of Veterinarians from 2000-2009. He also works as an organization development consultant, emphasizing strategic planning and leadership development with inclusion as a core element.

Author:

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

The Agenda

You can download our agenda here.

Simply fill in this form and we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.

Brasil, PT   Português

          Español

 

Animal Health Innovation Latam agenda 2019

Download the Agenda

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Speakers

 

José Francisco Ortiz Collado

Sr. Vice President and General Manager Brazil & South Latin-American Region
Zoetis

Responsible for leading Argentina, Uruguay, Paraguay, Chile, Peru, Ecuador, Bolivia on top of continuing in charge of Brazilian business to assure success of Zoetis strategy in the whole region with expansion in Cattle and Companion Animal segments and developing regional Key Account Strategy for Swine and Poultry and expanding Zoetis presence into adjacent spaces such as Aquaculture.

José Francisco Ortiz Collado

Sr. Vice President and General Manager Brazil & South Latin-American Region
Zoetis

José Francisco Ortiz Collado

Sr. Vice President and General Manager Brazil & South Latin-American Region
Zoetis

Responsible for leading Argentina, Uruguay, Paraguay, Chile, Peru, Ecuador, Bolivia on top of continuing in charge of Brazilian business to assure success of Zoetis strategy in the whole region with expansion in Cattle and Companion Animal segments and developing regional Key Account Strategy for Swine and Poultry and expanding Zoetis presence into adjacent spaces such as Aquaculture.

Responsible for leading Argentina, Uruguay, Paraguay, Chile, Peru, Ecuador, Bolivia on top of continuing in charge of Brazilian business to assure success of Zoetis strategy in the whole region with expansion in Cattle and Companion Animal segments and developing regional Key Account Strategy for Swine and Poultry and expanding Zoetis presence into adjacent spaces such as Aquaculture.

 

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health

Clóvis De Oliveira

Head of Latin American Region
Boehringer Ingelheim Animal Health
 

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health

Carlos Alberto Kuada

Vice President Latin America
Elanco Animal Health
 

Raquel Moutinho Barbosa

Business Development Manager
Inova Unicamp

Raquel Moutinho Barbosa

Business Development Manager
Inova Unicamp

Raquel Moutinho Barbosa

Business Development Manager
Inova Unicamp
 

Ariel Pereda

Animal Health Program Coordinator
INTA

Ariel Pereda

Animal Health Program Coordinator
INTA

Ariel Pereda

Animal Health Program Coordinator
INTA
 

Fernanda Ferrari

Contract Advisor
UNESP

Fernanda Ferrari

Contract Advisor
UNESP

Fernanda Ferrari

Contract Advisor
UNESP
 

Nelson Rojas Velis

Executive Director
INNBIO, Universidad de Concepción

Nelson Rojas Velis

Executive Director
INNBIO, Universidad de Concepción

Nelson Rojas Velis

Executive Director
INNBIO, Universidad de Concepción
 

Elcio Ihne

President
SINDAN

Elcio Ihne

President
SINDAN

Elcio Ihne

President
SINDAN
 

Carolina Padovani

Scientific Affairs & Communication Manager
Royal Canin Brazil

Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.

Carolina Padovani

Scientific Affairs & Communication Manager
Royal Canin Brazil

Carolina Padovani

Scientific Affairs & Communication Manager
Royal Canin Brazil

Carolina Padovani has been the Scientific Affairs & Communication Manager at Royal Canin Brazil since January 2016. Her backgroud is in veterinary medicine and she has a master's degree in pet nutrition. She started her career at Royal Canin with a regulatory affairs implementation area in 2010. Since then she has developed some projects and get the opportunity to navigate in different areas such as R&D, MKT, Corporate Affairs, Public Affairs. In her current position, she manages the areas of technical knowledge and relationship with KOL and universities.

 

Jose Guilherme Tollstadius Leal

Secretary of Defense for Agriculture and Livestock (SDA)
Ministry of Agriculture, Livestock and Supply (MAPA)

Jose Guilherme Tollstadius Leal

Secretary of Defense for Agriculture and Livestock (SDA)
Ministry of Agriculture, Livestock and Supply (MAPA)

Jose Guilherme Tollstadius Leal

Secretary of Defense for Agriculture and Livestock (SDA)
Ministry of Agriculture, Livestock and Supply (MAPA)
 

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer

Matias de Juan

Animal Health Business Unit Manager
Laboratorios Sanfer
 

Dr. Daniel Yoshimy Hato

Owner
Dr. Hato Veterinary Hospital

Dr. Daniel Yoshimy Hato

Owner
Dr. Hato Veterinary Hospital

Dr. Daniel Yoshimy Hato

Owner
Dr. Hato Veterinary Hospital
 

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

PROFILE:

- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.

- Support for technical and regulatory affairs for new and existing business.

- Support for development of new businesses in Brazil for global players.

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

Byron Silva

Business and Regulatory Affairs Consultant
Vet Affairs Ltd

PROFILE:

- Veterinary with expertise for over 35 years in veterinary products segment working for local and global players. Previous experience in several areas of veterinary industry: vaccine production, QC, R&D, product manager, technical assistance and regulatory affairs.

- Support for technical and regulatory affairs for new and existing business.

- Support for development of new businesses in Brazil for global players.

 

Dr. Gustaco Adolfo Garcia Sanchez

CEO & President, Santgar International Animal Health
CEO & President, Vaterinary Opthalmology For The World

Dr. Gustaco Adolfo Garcia Sanchez

CEO & President, Santgar International Animal Health
CEO & President, Vaterinary Opthalmology For The World

Dr. Gustaco Adolfo Garcia Sanchez

CEO & President, Santgar International Animal Health
CEO & President, Vaterinary Opthalmology For The World
 

Dr. Eduardo Pacheco

Veterinarian and Veterinary Hospital Manager
Santa Ines Vet Hospital

Dr. Eduardo Pacheco

Veterinarian and Veterinary Hospital Manager
Santa Ines Vet Hospital

Dr. Eduardo Pacheco

Veterinarian and Veterinary Hospital Manager
Santa Ines Vet Hospital
 

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio

Commercial Manager
Dechra Pharmaceuticals

Gustavo Osorio is a Mexican Veterinarian who started his successful career in the Animal Health Industry as sales representative for companion animal products with Pfizer Animal Health, where he gained commercial experience working with distributors and third party sales forces.

During his tenure in Pfizer Animal Health, Gustavo held different position of increased responsibility. He worked as Technical Manager for Companion Animal being responsible for technical trainings for the team as well as speaker in different events. He was promoted to Sales Force Manager, working in a sales efficiency project while starting his incursion in marketing, this movement allowed him to move to the Marketing Manager position.

In 2006, Gustavo joined Bayer Animal Health as Marketing Manager for Companion Animals. During his 8 year tenure, he contributed to the evolution of the business unit by introducing new lines of products while managing the growth of the companion animals portfolio.

From 2014 to 2018, Gustavo was Influencer Marketing Manager for Eukanuba at Mars. This position allowed him to better understand the motivations and habits of pet owners as well as learn from the pet food industry and gain a new set of skills oriented at the commercial models applied in this segment.

 

Since 2018, Gustavo is the Commercial Manager for Mexico, Central America and the Caribbean at Dechra Brovel, the Mexican subsidiary of Dechra. He is focused on the transformation of the company structure from a family owned company to an international corporation, successfully launching specialized products such as Vetoryl and Zycortal while maintaining the growth of the generic products business. He is also developing and strengthening his team to address future challenges.

 

Dr. Tony Zi Long Tan

Founder and Managing Partner
Z-LINK BIOTECH

Dr. Tan has over 30 years experience in the field of animal health across a range of animal species. He has had management roles in R&D, regulatory affairs, manufacturing, marketing, sales, and business development. Dr. Tan has extensive international business experience and has worked in the USA, Europe and Asia (particularly in China). Dr. Tan is the founder and Managing Partner of Z-Link Biotech Co. Ltd., a service and support company that helps animal health organizations to achieve their growth and stakeholder value in the emerging market.

Dr. Tony Zi Long Tan

Founder and Managing Partner
Z-LINK BIOTECH

Dr. Tony Zi Long Tan

Founder and Managing Partner
Z-LINK BIOTECH

Dr. Tan has over 30 years experience in the field of animal health across a range of animal species. He has had management roles in R&D, regulatory affairs, manufacturing, marketing, sales, and business development. Dr. Tan has extensive international business experience and has worked in the USA, Europe and Asia (particularly in China). Dr. Tan is the founder and Managing Partner of Z-Link Biotech Co. Ltd., a service and support company that helps animal health organizations to achieve their growth and stakeholder value in the emerging market.

Dr. Tan received his veterinary degree from Foshan Veterinary College in China, his Master’s Degree in Animal Science from Alcorn State University, and his Ph.D. in Microbiology from Kansas State University. During his earlier research career, Dr. Tan helped develop several vaccines for cattle, dogs, and poultry. He has published over 50 scientific publications and research reports.

Dr. Tan served Intervet-Schering Plough (now Merck/MSD Animal Health) for over 15 years in different positions, including R&D Group Leader, Project Manager Vaccine Manufacturing, Technical Marketing Manager Aquatic Animals, and Business Unit Director Companion Animals China.

From 2009 to March 2016, Dr. Tan was Group Director of Business Development and Global Alliances for the Asia-Pacific Region of Zoetis (formerly Pfizer Animal Health). He successfully completed several large M&A transactions (total transaction value in excess of US$100 million) and a number of technology licensing deals. These include the first antitrust divesture project in China, the company’s first joint venture project for vaccine manufacturing, and divesture of a pharmaceutical manufacturing plant in Taiwan.

Dr. Tan is an Advisor to the China Global Investment & Trading Alliance (CGITA), an organization that promotes international business between China and other countries.

谭博士在动物保健领域从业超过30年,涉及各种动物品种和岗位部门,包括研发、产品注册、生产、市场、销售以及业务拓展。谭博士拥有丰富的国际工作经验,曾在美国、欧洲和亚洲(特别是中国)国家工作。谭博士是易联生物科技有限公司的创始人。易联生物科技是一家咨询公司帮助动保公司在新兴市场服的发展。

谭博士毕业于佛山兽医专科学校、从阿尔肯州立大学取得了动物科学的硕士学位、从堪萨斯州立大学取得了微生物学的博士学位。在他的研究生涯中,为牛、狗以及家禽类开发了数种疫苗,并且发表了超过50篇科学论文和研究报告。

谭博士在英特威/默沙东动物保健公司工作了超过15年,期间担任了不同职位,包括研发部主管、疫苗制造项目经理、水生动物的技术市场经理以及中国伴侣动物的事业部总监。

从2009年到2016年,谭博士在硕腾(原名辉瑞)担任业务拓展部门和国际联盟亚太地区高级总监。他成功地完成了数项重大企业并购交易(总交易额超过一亿美元)和若干技术转让项目。其中包括中国第一个反垄断剥离项目,辉瑞在中国的第一个合资企业和出售台湾的一家医药制造工厂。

此外,谭博士还是中国际投资和贸易联盟(CGITA)的顾问。CGITA是一个致力于促进中国和其他国家之间国际商务的组织。

 

Dr. Klaus Hellmann

Chief Veterinary Officer
Argenta

Dr. Klaus Hellmann

Chief Veterinary Officer
Argenta

Dr. Klaus Hellmann

Chief Veterinary Officer
Argenta
 

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG

Arthur Gabriel da Silva

Strategic Alliances Analyst
CTIT UFMG
 

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG

Flávia De Marco Almeida

Intellectual Property Analyst - Biotechnology
CTIT UFMG
 

Richard Rainer

Partner
Olimpia Partners

Richard Rainer

Partner
Olimpia Partners

Richard Rainer

Partner
Olimpia Partners
 

Rodrigo Galvao

Managing Director
Acon Investments

Rodrigo Galvao

Managing Director
Acon Investments

Rodrigo Galvao

Managing Director
Acon Investments
 

Esteban Corrales

Director
LABYES

Esteban Corrales

Director
LABYES

Esteban Corrales

Director
LABYES
 

Maricel Saenz

Co-Founder
Nextbiotics

Maricel Saenz

Co-Founder
Nextbiotics

Maricel Saenz

Co-Founder
Nextbiotics
 

Bernardo Arrospide

Chairman of the Board
4Vets

Bernardo Arrospide

Chairman of the Board
4Vets

Bernardo Arrospide

Chairman of the Board
4Vets
 

Bruno Ducatti

Co-Founder
Vet Smart

Entrepreneur and co-creator of the company, and developer of Brazil's largest platform of online communication between companies and veterinarians. Participation in the design of new products. Acting with commercial negotiations and strategic partnerships. Expertise in mobile technology and communication and branding strategies.

-----

Bruno Ducatti

Co-Founder
Vet Smart

Bruno Ducatti

Co-Founder
Vet Smart

Entrepreneur and co-creator of the company, and developer of Brazil's largest platform of online communication between companies and veterinarians. Participation in the design of new products. Acting with commercial negotiations and strategic partnerships. Expertise in mobile technology and communication and branding strategies.

-----

Empreendedor e co-criador da empresa desenvolvedora da maior plataforma do Brasil de comunicação online entre empresas e médicos veterinários. Participação na concepção de novos produtos. Atuação com negociações comerciais e parcerias estratégicas. Expertise em tecnologia mobile e em estratégias de comunicação e branding.

 

Luiz Luccas

Founder
ALPHA HLD

Luiz Luccas

Founder
ALPHA HLD

Luiz Luccas

Founder
ALPHA HLD
 

Delair Bolis

President, SINDAN, AVP, MSD
SINDAN

Delair Bolis

President, SINDAN, AVP, MSD
SINDAN

Delair Bolis

President, SINDAN, AVP, MSD
SINDAN
 

Mauricio Motta

CEO
Logvett

Mauricio Motta

CEO
Logvett

Mauricio Motta

CEO
Logvett
 

Rita Costoya

Head of Technology Transfer
UNESP

Rita Costoya

Head of Technology Transfer
UNESP

Rita Costoya

Head of Technology Transfer
UNESP
 

Yoshihiro Shimizu

DVM
Vetco Pharmaceuticals Inc.

Yoshihiro Shimizu

DVM
Vetco Pharmaceuticals Inc.

Yoshihiro Shimizu

DVM
Vetco Pharmaceuticals Inc.
 

Jesse Hoff

Chief Science Officer
Rex Animal Health

Jesse Hoff

Chief Science Officer
Rex Animal Health

Jesse Hoff

Chief Science Officer
Rex Animal Health

Headline Partner

Associate Partners

Senior Event Partner

Media Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Press Partnerships

Whether you are an association, embassy, industry body or publication, we can offer a tailored marketing partnership to suit your needs. As a Media Partner we can:

  • Promote your organisation as an event partner across all conference materials, including the website, brochure, emails and on-site programme
  • Offer your members or readers a discount on their registration fee for Animal Health Investment Europe
  • Provide one free press pass to attend
  • Distribute promotional materials at the conference

If you are a registered industry journalist or member of the press and would like to arrange an interview with a speaker or to discuss the event please contact:

Jessica Parry
Senior Marketing Manager
T: +44 (0)203 696 2920
E: [email protected]

Venue

São Paulo, Brasil

This year's Animal Health Innovation Latam will be held at:

Hotel Pullman São Paulo Guarulhos Airport
Rodovia Hélio Smidt, s/n , Acesso Base Aerea Cumbica –
Aeroporto, Guarulhos - SP, 07190-100, Brazil

Delegates can benefit from a discounted accommodation rate of R$500 + VAT per night

To book at this price please email the hotel reservation center: [email protected] and quote 'Kisaco Research, August'

Hotel website >>

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.